Nectar Lifesciences Limited

NSE:NECLIFE.NS

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🧱 Cement

🔬 Clinical Trials

🏗 Construction Materials

🌿 Fertilizers

💊 Pharmaceuticals

Location

India

Market Cap

USD 58.67 M

Share Price

USD 0.26

Avg Daily Volume

1,530,215

Change (1 day)

0.38%

Change (1 year)

-31.65%

Change (YTD)

-42.65%

Nectar Lifesciences Limited Share Price on June 26, 2025: USD 0.26

Nectar Lifesciences Limited Share Price is USD 0.26 on June 26, 2025, a -31.65% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Nectar Lifesciences Limited 52-week low Share Price is USD 0.64 on June 26, 2025, which is 145.98% above the current Share Price.
Nectar Lifesciences Limited 52-week low Share Price is USD 0.24 on June 26, 2025, which is -8.10% below the current Share Price.
Nectar Lifesciences Limited average Share Price for the last 52 weeks is USD 0.38.

Daily

From:

To:

Zoom:

Key data

Date	Share Price	Share Price	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)

NSE: NECLIFE.NS

Nectar Lifesciences Limited

CEO	Mr. Amit Chadah
IPO Date	July 18, 2005
Location	India
Headquarters	SCO 38-39
Employees	1,686
Sector	🏥 Health Care
Industries Drugstores & Retail Pharmacies 🧱 Cement 🔬 Clinical Trials 🏗 Construction Materials 🌿 Fertilizers 💊 Pharmaceuticals

Description

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.